Pneumothorax as a Poor Prognostic Indicator in Covid-19 in Turkey: a Propensity Score Matching Analysis
| dc.contributor.author | Özgel, M. | |
| dc.contributor.author | Gülçek, I. | |
| dc.contributor.author | Aǧar, M. | |
| dc.contributor.author | Ulutaş, H. | |
| dc.date.accessioned | 2024-09-22T13:31:48Z | |
| dc.date.available | 2024-09-22T13:31:48Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Background: Spontaneous pneumothorax in COVID-19 occurs infrequently but in up to 15% of patients dependent on mechanical ventilation (MV). Pneumothorax-related deaths account for 1% of all COVID-19-related deaths. Aim: To determine factors associated with pneumothorax in COVID-19 patients and the effect of pneumothorax on early survival. Methods: This was a retrospective study of 4799 COVID-19-positive hospitalized patients. The groups were homogenized using propensity score matching (PSM) in two groups comprising 67 COVID-19 patients each. The prevalence of pneumothorax was determined. Multiple logistic regression was used to determine factors associated with pneumothorax. P value < 0.05 was taken as significant. Results: The prevalence of pneumothorax in COVID-19 patients was 1.6%. Lung disease, comorbidities, and oxygen support, which were significantly different between the two groups before PSM, were homogenized after PSM. In a univariate analysis, symptom duration (P 0.001), neutrophilia (P 0.001), lymphopenia (P 0.001), neutrophil-lymphocyte ratio (P = 0.003), ferritin levels (P = 0.012), D-dimer levels (P = 0.011), MV support (P 0.001), antibiotherapy (P 0.001), length of hospital stay (P = 0.009), and death (P = 0.002) differed significantly between the groups. Pneumothorax had a significant negative effect on survival (32.8% vs. 59.7%, P = 0.01). In a multivariate regression model, factors associated with pneumothorax were duration of symptoms (Adjusted Odds ratio (AOR) 1.68; 95% Confidence Interval (CI): 1.26-2.25; P = 0.001), mechanical ventilation (AOR 23.92; 95% CI: 4.12-138.72; P = <0.001), dual antibiotics (AOR 8.28; 95% CI: 1.56-43.86; P = 0.013), neutrophilia (AOR: 1.08; 95% CI: 1.02-1.14; P = 0.011), and lymphopenia (AOR: 0.92; 95% CI: 0.86-0.90; P = 0.022). Conclusion: The presence of pneumothorax was associated with poor survival in COVID-19 patients. Patients with a prolonged time from symptom onset to treatment and those dependent on mechanical ventilation in intensive care were in the high risk group for the development of pneumothorax. Copyright © 2024 Nigerian Journal of Clinical Practice. | en_US |
| dc.identifier.doi | 10.4103/njcp.njcp_785_23 | |
| dc.identifier.issn | 1119-3077 | |
| dc.identifier.issn | 2229-7731 | |
| dc.identifier.scopus | 2-s2.0-85202184412 | |
| dc.identifier.uri | https://doi.org/10.4103/njcp.njcp_785_23 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/5535 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wolters Kluwer Medknow Publications | en_US |
| dc.relation.ispartof | Nigerian Journal of Clinical Practice | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | COVID-19; pneumothorax; prognostic factors; survival | en_US |
| dc.subject | Adult; Aged; Comorbidity; COVID-19; Female; Humans; Male; Middle Aged; Pneumothorax; Prevalence; Prognosis; Propensity Score; Respiration, Artificial; Retrospective Studies; Risk Factors; SARS-CoV-2; Turkey; adult; aged; artificial ventilation; comorbidity; complication; coronavirus disease 2019; epidemiology; female; human; male; middle aged; mortality; pneumothorax; prevalence; prognosis; propensity score; retrospective study; risk factor; Severe acute respiratory syndrome coronavirus 2; turkey (bird) | en_US |
| dc.title | Pneumothorax as a Poor Prognostic Indicator in Covid-19 in Turkey: a Propensity Score Matching Analysis | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | … | |
| gdc.author.scopusid | 6504284733 | |
| gdc.author.scopusid | 57725467000 | |
| gdc.author.scopusid | 57220439354 | |
| gdc.author.scopusid | 14052797100 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | Özgel M., Department of Thoracic Surgery, Malatya Training Research Hospital, Malatya Turgut Ozal University, Medical Faculty, Malatya, Turkey; Gülçek I., Department of Thoracic Surgery, Gaziantep City Hospital, Gaziantep, Turkey; Aǧar M., Department of Thoracic Surgery, Elazig Fethi Sekin City Hospital, Elazig, Turkey; Ulutaş H., Department of Thoracic Surgery, Medical Point Hospital, Izmir Economy University, Izmir, Turkey | en_US |
| gdc.description.endpage | 964 | en_US |
| gdc.description.issue | 8 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 958 | en_US |
| gdc.description.volume | 27 | en_US |
| gdc.description.wosquality | Q3 | |
| gdc.identifier.openalex | W4401889668 | |
| gdc.identifier.pmid | 39212431 | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Male | |
| gdc.oaire.keywords | Adult | |
| gdc.oaire.keywords | Turkey | |
| gdc.oaire.keywords | SARS-CoV-2 | |
| gdc.oaire.keywords | COVID-19 | |
| gdc.oaire.keywords | Pneumothorax | |
| gdc.oaire.keywords | Comorbidity | |
| gdc.oaire.keywords | Middle Aged | |
| gdc.oaire.keywords | Prognosis | |
| gdc.oaire.keywords | Respiration, Artificial | |
| gdc.oaire.keywords | Risk Factors | |
| gdc.oaire.keywords | Prevalence | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Female | |
| gdc.oaire.keywords | COVID‑19, pneumothorax, prognostic factors, survival | |
| gdc.oaire.keywords | Propensity Score | |
| gdc.oaire.keywords | Retrospective Studies | |
| gdc.oaire.keywords | Aged | |
| gdc.oaire.popularity | 2.3737945E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.25 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 3 | |
| gdc.plumx.scopuscites | 0 | |
| gdc.scopus.citedcount | 0 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 |
